Patient-reported-outcomes In Chronic Cervical Pain Patients With Accompanying Upper Limb Radiating Pain (Neuropathic Component) Treated With Pregabalin In Primary Care Settings
Phase of Trial: Phase IV
Latest Information Update: 22 Sep 2017
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Sponsors Pfizer; Pfizer Japan
- 18 Sep 2017 Planned End Date changed from 1 Oct 2017 to 1 Nov 2017.
- 18 Sep 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Nov 2017.
- 12 Sep 2016 Status changed from not yet recruiting to recruiting.